Infections of the nervous system

Lancet Neurology

Volumn 4, Issue 1, 2005, Pages 12-13

  Gendelman, Howard E ^a   Persidsky, Yuri ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; BIOLOGICAL WARFARE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE COURSE; DRUG DELIVERY SYSTEM; ERADICATION THERAPY; FEASIBILITY STUDY; HUMAN; MEDICAL RESEARCH; MENINGOCOCCOSIS; MOLECULAR EVOLUTION; PATHOGENESIS; POLIOMYELITIS; PRIORITY JOURNAL; PROPHYLAXIS; REDUCTION; THALAMUS POSTERIOR NUCLEUS;

EID: 11144284583     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00951-2     Document Type: Note

References (7)

1. Leroy EM, Rouquet P, Formenty P, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 303:2004;387-390
2. Casalone C, Zanusso G, Acutis P, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA. 101:2004;3065-3070
3. Harrison SC, Alberts B, Ehrenfeld E, et al. Discovery of antivirals against smallpox. Proc Natl Acad Sci USA. 101:2004;11178-11192
4. Roberts L. Polio: health workers scramble to contain African epidemic. Science. 305:2004;24-25
5. Reinert RR. Pneumococcal conjugate vaccines: a European perspective. Int J Med Microbiol. 294:2004;277-294
6. Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 364:2004;365-367
7. Verez-Bencomo V, Fernandez-Santana V, Hardy E, et al. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science. 305:2004;522-525